As the global economy recovers in 2021 and the supply of the industrial chain improves, the Antipsychotic Drug market will undergo major changes. According to the latest research, the market size of the Antipsychotic Drug industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.

The global Antipsychotic Drug industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.

The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Antipsychotic Drug market during the next few years. The global Antipsychotic Drug market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.

Highlights-Regions

The Antipsychotic Drug market can be split based on product types, major applications, and important regions as follows:

North America
Europe
China
Japan
Southeast Asia
India
Korea

Player list
Johnson & Johnson
Pfizer
Eli Lilly
Bristol Myers Squibb
AstraZeneca
Sumitomo Dainippon Pharma
Allergan
Novartis
Cardinal Health
Sun Pharmaceutical Industries
GlaxoSmithKline
Sanis Health
Qilu Pharmaceutical
Otsuka Pharmaceutical
Vanda Pharmaceuticals
H.Lundbeck
Organon
Hansoh
Hengrui
Nhwa Group
Yangtze River Pharmaceutical Group

Types list
First Generation Antipsychotics Drug
Second Generation Antipsychotics Drug
Third generation Antipsychotics Drug

Application list
Bipolar I Disorder
Schizophrenia
Schizoaffective Disorder
Others